MedPath

Clinical and Fundamental Aspects of Prosthetics and Translocation of Mitral Valve Chordae

Not Applicable
Active, not recruiting
Conditions
Degenerative Mitral Valve Disease
Interventions
Procedure: Mitral valve chordae prosthesis
Procedure: Mitral valve chordae translocation
Registration Number
NCT03674593
Lead Sponsor
Tomsk National Research Medical Center of the Russian Academy of Sciences
Brief Summary

The study compares the efficacies of two surgical procedures for the treatment of mitral valve prolapse due to myxomatous degeneration of the mitral valve: the chordae replacement and the translocation of secondary mitral valve chordae.

Detailed Description

Summary: This study compares the efficacy and the safety of two surgical procedures for the treatment of mitral valve prolapse due to degeneration of the mitral valve: chordae replacement and the translocation of secondary mitral valve chordae.

In our study, researchers used the loop method proposed by von Oppel and Mohr in 2000. The main principle of the method of prosthetic chordae is the preservation of the native anatomy of the mitral valve. This principle is achieved by the implantation of artificial chordae made of ePTFE Gore-Tex threads.

The chordae replacement method essentially involves five stages:

1. Measuring the required length of the chordae.

2. Forming the loops.

3. Fixation of the group of loops to the papillary muscles.

4. Fixation of the chordal loops to the free edge of the valve.

5. Annuloplasty with a support ring and a hydraulic test to confirm the absence of prolapse.

Chordae translocation is the alternative method, which does not require measurement and selection of chordae lengths. Chordae replacement is technically easier (less aortic clamping time) with comparable results.

The technique of translocation of secondary chordae essentially consists of three stages:

1. Selection of the secondary chordae.

2. Fixation of secondary chordae to the free edge of the valve.

3. Annuloplasty support ring and hydraulic test to confirm the absence of prolapse.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
64
Inclusion Criteria
  1. Isolated type II mitral valve insufficiency by A. Carpentier
  2. Mitral regurgitation degree >2
  3. Age >18 years
  4. Signed informed consent to participate in the study
Exclusion Criteria
  1. Any other cardiac surgeries
  2. Age <18 years
  3. Multiple organ failure
  4. ReDo procedure
  5. Persistent atrial fibrillation
  6. Acute infective endocarditis
  7. Refusal to sign informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Mitral valve chordae prosthesisMitral valve chordae prosthesisPatients of this group receive mitral valve chordae replacement performed in five stages: 1. Measure the required length of the chordae. 2. Forming loops. 3. Fixation of the loop group to the papillary muscles. 4. Fixation of chordal loops to the free edge of the valve. 5. Annuloplasty with a support ring and a hydraulic test to confirm the absence of prolapse.
Mitral valve chordae translocationMitral valve chordae translocationThe technique of translocation of secondary chordae: The method consists essentially of three stages: 1. Selection of the secondary chordae. 2. Fixation of secondary chordae to the free edge of the valve. 3. Annuloplasty support ring and hydraulic test to confirm the absence of prolapse.
Primary Outcome Measures
NameTimeMethod
Mitral regurgitation degree measureTwo weeks

Mitral regurgitation degree (from 1 to 4) assessed by echocardiography two weeks after surgery

Secondary Outcome Measures
NameTimeMethod
Surgical efficacy measureOne year

Mitral regurgitation degree (from 1 to 4) assessed by echocardiography one year after surgery

ERO measureTwo weeks

Effective regurgitant orifice (ERO) (in square millimeters) assessed by echocardiography two weeks after surgery

Trial Locations

Locations (1)

Cardiology Research Institute, Tomsk NRMC

🇷🇺

Tomsk, Russian Federation

© Copyright 2025. All Rights Reserved by MedPath